IGMS IGM Biosciences: Forvard P/S multiplikatori
IGM Biosciences, Inc. (IGMS) o'zining strategik yo'nalishini butunlay o'zgartirib, onkologiyadan voz kechgan holda autoimmun patologiyalarga qarshi kurashishga e'tibor qaratdi. Joriy strategiya IgM antitelalarning joriy etilishi va Sanofi tomonidan ko'rsatilgan qo'llab-quvvatlashga asoslangan bo'lib, bu forward P/S baholanishida aks etgan, bunda 0.30 joriy ko'rsatkichni ifodalaydi. Biznes qiymatining o'sishi endilikda klinik sinovlardagi progress va yangilangan sheriklik ma'lumotlariga bog'liq.
IGM Biosciences (IGMS) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil
- joriy narx va aksiyalarning prognoz qilingan qiymati:
- kompaniya aksiyalari kapitallashuvi ma'lumotlari:
- emitentning balans qiymati statistikasi:
- kompaniyaning majburiyatlari va likvidligi ma'lumotlari:
Umumiy qarzning xususiy kapitalga nisbati IGM Biosciences, Inc.|IGMS - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning kapitalga nisbati IGM Bio|IGMS - Kompaniya qarzlari|Balans kapitallashuviga qarzlar IGM Bio|IGMS - Uzoq muddatli qarz hajmi|Kompaniyaning qisqa muddatli qarzi IGM Biosciences|Tezkor likvidlik igmbio.com
- moliyaviy natijalar va qiymat multiplikatorlari tafsilotlari:
IGMS - Sof moliyaviy natija|Prognoz qilingan kelajakdagi foyda IGM Biosciences, Inc.|IGMS - Narx-foyda koeffitsiyenti|Forvard P/E multiplikatori igmbio.com|IGMS - O‘sish sur’atini hisobga olgan kapitalizatsiyaning sof foydaga nisbati|EV/EBITDA multiplikatori IGM Biosciences, Inc.|IGMS - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi o'n ikki oy davomida bir aksiya uchun foyda IGM Biosciences|IGMS - So'nggi 12 oy davomida bir aksiya uchun foyda|Choraklik EPS foyda o'sishi igmbio.com|IGMS - Bu yil bir aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi IGM Biosciences, Inc.
- tushum va sotishdan olingan daromadlar ma'lumotlari:
Kompaniyaning jamlanma tahliliyoti:IGM Biosciences Inc. IGMS
Forward P/S aktivning bozor qiymatini kutilayotgan savdo hajmi bilan nisbatda o'lchaydi, bu esa tashqi shoklar paytida narxlar tebranishi amplitudasini baholash imkonini beradi. IGM Biosciences, Inc. (IGMS) uchun forward P/S grafigining tahlili kapitalizatsiyaning daromad o'sish sur'atlariga sezgirligini ko'rsatadi, bu esa IGM Biosciences, Inc. (IGMS) uchun onkologiya bo'limini qisqartirish va Sanofi bilan hamkorlikda organik R&D sinovlariga o'tish davrida juda muhimdir.
Raqobatdosh kompaniyalar tahlili
Forvard P/S multiplikatori ARGX (argenx.com)|BioNTech Group (BNTX) - Bozor kapitallashuvining kelajakdagi daromadga nisbati|ABIVAX - Forvard P/S multiplikatori|ADMA - Forvard P/S multiplikatori|Protagonist (PTGX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Immunovant Inc|Narxning prognoz qilingan daromadga nisbati Kiniksa Pharmaceuticals|Grifols Group (GRFS) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Narxning prognoz qilingan daromadga nisbati Adaptive Biotechnologies Corp (ADPT)|Narxning prognoz qilingan daromadga nisbati CLDX (Celldex Therapeutics)|Narxning prognoz qilingan daromadga nisbati Aurinia Pharma AUPH|Sotuvga nisbatan forvard narx BCRX|VERA: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx DNTH (Dianthus Therapeutics)|Pharvaris N.V. (PHVS) - Narxning prognoz qilingan daromadga nisbati|Bozor kapitallashuvining kelajakdagi daromadga nisbati AbCellera Biologics (ABCL)|TRML (Tourmaline Bio Inc) - Forvard P/S multiplikatori|Kapitalizatsiyaning prognoz qilingan daromadga nisbati PGEN (Intrexon)|Forvard narx/daromad multiplikatori PHAR (Pharming)|NKTR (Nektar) - Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori UPB (upstreambio.com)|ZBIO (Zenas Biopharma Inc) - Kelajakdagi narxning daromadga nisbati|IMNM - Narxning prognoz qilingan daromadga nisbati|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Gossamer Bio Inc GOSS|KALV: Forvard P/S multiplikatori|Forvard narx/daromad multiplikatori Septerna Pharma|PVLA (Pieris Corp) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati SVRA|Forvard P/S multiplikatori RIGL|Forvard narx/daromad multiplikatori AnaptysBio Corp ANAB|Astria Therapeutics Inc - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati enGene Holdings Inc. (ENGN)|RAPT Therapeutics Inc. - Forvard P/S multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Aerovate Therapeutics, Inc.|ACRS (Aclaris Therapeutics) - Forvard narx/daromad multiplikatori|KYTX: Narxning kutilayotgan daromadga nisbati|Narxning prognoz qilingan daromadga nisbati Tiziana Life Sciences|Cabaletta Bio, Inc (CABA) - Kapitalizatsiyaning kutilayotgan sotuvga nisbati|Forvard narx/daromad multiplikatori VTYX (Ventyx Biosciences)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati theratech.com|Forvard P/S multiplikatori AVTX (Avalo Therapeutics, Inc.)|Forvard P/S multiplikatori Eledon Pharmaceuticals Inc. ELDN|AGEN: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx CLYM (Climb Bio, Inc)|ZURA: Forvard P/S multiplikatori|aTyr Pharma, Inc. - Sotuvga nisbatan forvard narx|Narxning prognoz qilingan daromadga nisbati Adagene Inc.|IMA: Sotuvga nisbatan forvard narx|Forvard P/S multiplikatori STTK|Forvard narx/daromad multiplikatori Equillium Bio EQ|Narxning prognoz qilingan daromadga nisbati Connect Biopharma CNTB|IMUX - Forvard narx/daromad multiplikatori|ATRA - Narxning prognoz qilingan daromadga nisbati|InflaRx NV (IFRX) - Forvard narx/daromad multiplikatori|XFOR (X4 Pharmaceuticals Inc.) - Forvard narx/daromad multiplikatori|Bozor kapitallashuvining kelajakdagi daromadga nisbati Adicet Bio Inc. (ACET)|Narxning prognoz qilingan daromadga nisbati celularity.com|Forvard narx/daromad multiplikatori inmunebio.com (INMB)|Narxning prognoz qilingan daromadga nisbati Barinthus Biotherapeutics PLC (BRNS)|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Kezar Life Sciences Inc.|SAB Biotherapeutics, Inc - Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati Akari Therapeutics, Plc (AKTX)|ENLV: Forvard narx/daromad multiplikatori|Sotuvga nisbatan forvard narx QTTB (q32bio.com)|GeoVax Labs Inc (GOVX) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori Edesa|Narxning prognoz qilingan daromadga nisbati iBio, Inc.|Forvard narx/daromad multiplikatori carismatx.com (CARM)|Forvard P/S multiplikatori XTLB|Forvard narx/daromad multiplikatori Bolt Bio BOLT|Forvard P/S multiplikatori HCWB (HCW Biologics)|APVO: Kapitalizatsiyaning prognoz qilingan daromadga nisbati|AIM - Narxning prognoz qilingan daromadga nisbati|ADTX - Forvard P/S multiplikatori|GRI Bio (GRI) - Narxning prognoz qilingan daromadga nisbati|Forvard narx/daromad multiplikatori XORTX Therapeutics|Narxning prognoz qilingan daromadga nisbati Vyome Therapeutics|Kapitalizatsiyaning prognoz qilingan daromadga nisbati REVB (Revelation Biosciences, Inc.)|Forvard P/S multiplikatori INDP|Forvard narx/daromad multiplikatori Scinai Immunotherapeutics SCNI|Forvard P/S multiplikatori CALI (CalciMedica)|AFMD - Forvard narx/daromad multiplikatori|ALLK: Forvard narx/daromad multiplikatori|Kapitalizatsiyaning kutilayotgan sotuvga nisbati HOOKIPA Pharma HOOK|ITOS (iTeos Therapeutics, Inc.) - Forvard narx/daromad multiplikatori|Ocean Biomedical Corp (OCEA) - Forvard P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati TC BioPharm (Holdings) PLC|Forvard P/S multiplikatori thirdharmonicbio.com
